| Date Filed | Type | Description |
| 06/12/2023 |
4
| Wigginton Jon Marc (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Granted 25,000 options to buy
@ $5.12, valued at
$128k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Wigginton Jon Marc (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 20,061 options to buy
@ $2.19, valued at
$43.9k
|
|
| 02/01/2022 |
3
| Wigginton Jon Marc (Director) has filed a Form 3 on Checkmate Pharmaceuticals, Inc. |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Wigginton Jon Marc (Chief Medical Officer) has filed a Form 4 on Cullinan Management, Inc.|
Txns:
| Granted 116,666 options to buy
@ $21, valued at
$2.4M
|
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2018 |
4
| Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 70,000 options to buy
@ $28.94, valued at
$2M
|
|
| 02/27/2018 |
4
| Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Paid exercise price by delivering 11,070 shares
@ $23.46, valued at
$259.7k
|
|
| 01/18/2018 |
4
| Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Sold 2,476 shares
@ $20, valued at
$49.5k
Sold 2,524 shares
@ $20, valued at
$50.5k
Exercised 2,476 options to buy
@ $4.7, valued at
$11.6k
Exercised 2,524 options to buy
@ $4.7, valued at
$11.9k
|
|
| 11/21/2017 |
4
| Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Sold 5,000 shares
@ $20, valued at
$100k
Exercised 5,000 options to buy
@ $4.7, valued at
$23.5k
|
|
| 10/26/2017 |
4
| Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Sold 10,000 shares
@ $20, valued at
$200k
Exercised 10,000 options to buy
@ $4.7, valued at
$47k
|
|
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/20/2017 |
4
| Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Sold 15,000 shares
@ $20, valued at
$300k
Exercised 15,000 options to buy
@ $4.7, valued at
$70.5k
|
|
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 10/19/2016 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 10/05/2016 |
4
| Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Sold 10,000 shares
@ $29.34, valued at
$293.4k
Exercised 10,000 options to buy
@ $4.7, valued at
$47k
|
|
| 08/03/2016 |
4
| Wigginton Jon Marc (Sr VP Clinical Dev & CMO) has filed a Form 4 on MACROGENICS INC|
Txns:
| Sold 20,000 shares
@ $30.78, valued at
$615.6k
Exercised 20,000 options to buy
@ $4.7, valued at
$94k
|
|
| 07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/09/2013 |
3
| Wigginton Jon Marc (Senior V P, Clinical Dev.) has filed a Form 3 on MACROGENICS INC |